What is IPAX?
IPAX operates as a full-service contract manufacturer and packager for medical devices, aiming to streamline the product launch process for entrepreneurial companies by reducing capital expenditure. The firm provides tailored finished medical device manufacturing and packaging services, accommodating both low-volume, quick-turnaround projects and high-volume, large-scale production demands. IPAX distinguishes itself through a commitment to superior customer service, rapid response times, and punctual delivery, ensuring a seamless client experience. Its facilities are FDA Registered and adhere to ISO 13485-2016 certification standards, reflecting a dedication to quality and innovation in its operations.
How much funding has IPAX raised?
IPAX has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for IPAX?
The substantial capital infusion, particularly the recent strategic investment, positions IPAX for accelerated growth and enhanced operational capabilities. As a company operating in a large-scale, late-stage funding environment, IPAX is likely to focus on expanding its manufacturing capacity, investing in advanced technologies, and potentially broadening its service offerings. This strategic financing will enable IPAX to solidify its market leadership, pursue new client acquisitions, and further innovate within the medical device supply chain, reinforcing its role as a critical partner for bringing medical innovations to market.
See full IPAX company page
